邻近类别 圖書 [1/1] 會議論文/會議摘要 [16/27] 类别统计 近3年内发表的文件:23(34.85%) 含全文笔数:65(98.48%) 文件下载次数统计 下载大于0次:65(100.00%) 下载大于100次:63(96.92%) 全文下载总次数:20552(77.97%) 最后更新时间: 2024-12-01 13:07 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Registry of genetic alterations of ... Systemic treatments in pancreatic c... The experience of neoadjuvant chemo... Real-world data validation of NAPOL... Elevated PD-L1 expression and micro... Adjuvant therapy in biliary tract c... The association between UGT1A1 poly... Revisiting the cerebral hemodynamic... A G-quadruplex stabilizer, CX-5461 ... Predictive value of albumin combine...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目11-20 / 66. (共7页) << < 1 2 3 4 5 6 7 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2022-11	CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer	British Journal of Cancer. 2022 Nov;127(9):1615-1628.
2022-10	The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma	Hepatology International. 2022 Oct;16(5):1137-1149.
2022-10	Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study	Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
2022-09-15	Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin	American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278.
2022-09	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	European Journal of Cancer. 2022 Sep;173:123-132.
2022-06-26	The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer	Cancers. 2022 Jun 26;14(13):Article number 3137.
2022-06-22	Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study	Frontiers in Oncology. 2022 Jun 22;12:Article number 800842.
2022-06-16	Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study	Therapeutic Advances in Medical Oncology. 2022 Jun 16;14:1-13.
2022-06-02	Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: A cohort study	Nutrition and Cancer. 2022 Jun 2;74(10):3546-3555.
2022-06	Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin	Journal of Hepato-Biliary-Pancreatic Sciences. 2022 Jun;54(5):607-612.

显示项目11-20 / 66. (共7页) << < 1 2 3 4 5 6 7 > >> 每页显示[10|25|50]项目